433 related articles for article (PubMed ID: 31308722)
1. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
Nguyen Q; Lim KRQ; Yokota T
Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish Models of
Fabian L; Dowling JJ
Front Mol Neurosci; 2020; 13():122. PubMed ID: 32742259
[TBL] [Abstract][Full Text] [Related]
3. Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
Hara Y; Mizobe Y; Miyatake S; Takizawa H; Nagata T; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1828():553-564. PubMed ID: 30171567
[TBL] [Abstract][Full Text] [Related]
4. Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG study.
Bouman K; Groothuis JT; Doorduin J; van Alfen N; Udink Ten Cate FEA; van den Heuvel FMA; Nijveldt R; van Tilburg WCM; Buckens SCFM; Dittrich ATM; Draaisma JMT; Janssen MCH; Kamsteeg EJ; van Kleef ESB; Koene S; Smeitink JAM; Küsters B; van Tienen FHJ; Smeets HJM; van Engelen BGM; Erasmus CE; Voermans NC
BMC Neurol; 2021 Aug; 21(1):313. PubMed ID: 34384384
[TBL] [Abstract][Full Text] [Related]
5. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy.
Hall TE; Bryson-Richardson RJ; Berger S; Jacoby AS; Cole NJ; Hollway GE; Berger J; Currie PD
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7092-7. PubMed ID: 17438294
[TBL] [Abstract][Full Text] [Related]
6. A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish.
Gupta VA; Kawahara G; Myers JA; Chen AT; Hall TE; Manzini MC; Currie PD; Zhou Y; Zon LI; Kunkel LM; Beggs AH
PLoS One; 2012; 7(8):e43794. PubMed ID: 22952766
[TBL] [Abstract][Full Text] [Related]
7. Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics.
Barraza-Flores P; Bates CR; Oliveira-Santos A; Burkin DJ
Front Mol Neurosci; 2020; 13():1. PubMed ID: 32116540
[TBL] [Abstract][Full Text] [Related]
8. Nerve pathology is prevented by linker proteins in mouse models for
Reinhard JR; Porrello E; Lin S; Pelczar P; Previtali SC; Rüegg MA
PNAS Nexus; 2023 Apr; 2(4):pgad083. PubMed ID: 37038437
[No Abstract] [Full Text] [Related]
9. Laminin-111 protein therapy after disease onset slows muscle disease in a mouse model of laminin-α2 related congenital muscular dystrophy.
Barraza-Flores P; Bukovec KE; Dagda M; Conner BW; Oliveira-Santos A; Grange RW; Burkin DJ
Hum Mol Genet; 2020 Aug; 29(13):2162-2170. PubMed ID: 32472139
[TBL] [Abstract][Full Text] [Related]
10. Merosin-deficient congenital muscular dystrophy type 1a: detection of
Tran VK; Nguyen NL; Tran LNT; Le PT; Tran AH; Pham TLA; Lien NTK; Xuan NT; Thanh LT; Ta TV; Tran TH; Nguyen HH
Front Genet; 2023; 14():1183663. PubMed ID: 37388928
[No Abstract] [Full Text] [Related]
11. Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy.
Oliveira-Santos A; Dagda M; Wittmann J; Smalley R; Burkin DJ
Dis Model Mech; 2023 Jun; 16(6):. PubMed ID: 37021539
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F
Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
[TBL] [Abstract][Full Text] [Related]
13. Linker proteins restore basement membrane and correct
Reinhard JR; Lin S; McKee KK; Meinen S; Crosson SC; Sury M; Hobbs S; Maier G; Yurchenco PD; Rüegg MA
Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659438
[No Abstract] [Full Text] [Related]
14. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel LAMA2 c.2217G > A, p.(Trp739*) mutation in a Moroccan patient with congenital muscular dystrophy: a case report.
El Kadiri Y; Ratbi I; Laarabi FZ; Kriouile Y; Sefiani A; Lyahyai J
BMC Med Genomics; 2021 Apr; 14(1):113. PubMed ID: 33882917
[TBL] [Abstract][Full Text] [Related]
16. LAMA2-related myopathy: Frequency among congenital and limb-girdle muscular dystrophies.
Løkken N; Born AP; Duno M; Vissing J
Muscle Nerve; 2015 Oct; 52(4):547-53. PubMed ID: 25663498
[TBL] [Abstract][Full Text] [Related]
17. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein.
Nissinen M; Helbling-Leclerc A; Zhang X; Evangelista T; Topaloglu H; Cruaud C; Weissenbach J; Fardeau M; Tomé FM; Schwartz K; Tryggvason K; Guicheney P
Am J Hum Genet; 1996 Jun; 58(6):1177-84. PubMed ID: 8651294
[TBL] [Abstract][Full Text] [Related]
18. Laminin α1 reduces muscular dystrophy in dy
Gawlik KI; Harandi VM; Cheong RY; Petersén Å; Durbeej M
Matrix Biol; 2018 Sep; 70():36-49. PubMed ID: 29544677
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
